BACKGROUND: Ischemia causes an imbalance in mitochondrial metabolism and accumulation of nicotinamide adenine dinucleotide (NADH). We showed that anesthetic preconditioning (APC), like ischemic preconditioning, improved mitochondrial NADH energy balance during ischemia and improved function and reduced infarct size on reperfusion. Opening adenosine triphosphate-sensitive potassium (K(atp)) channels may be involved in triggering APC. The authors tested if effects of APC on NADH concentrations before, during, and after ischemia are reversible by 5-hydroxydecanoate (5-HD), a putative mitochondrial K channel blocker. METHODS: Nicotinamide adenine dinucleotide fluorescence was measured in 60 guinea pig Langendorff-prepared hearts assigned into five groups: (1) no treatment before ischemia; (2) APC by exposure to 1.3 mm sevoflurane for 15 min; (3) 200 microm 5-HD from 5 min before to 15 min after sevoflurane exposure; (4) 35 min 5-HD alone; and (5) no treatment and no ischemia. Sevoflurane was washed out for 30 min, and 5-HD for 15 min, before 30-min ischemia and 120-min reperfusion. RESULTS: Nicotinamide adenine dinucleotide was reversibly increased during sevoflurane exposure before ischemia, and the increase and rate of decline in NADH during ischemia were reduced after APC. 5-HD abolished these changes in NADH. On reperfusion, function was improved and infarct size reduced after APC compared with other groups. CONCLUSION: Anesthetic preconditioning was evidenced by improved mitochondrial bioenergetics as assessed from NADH concentrations during ischemia and by attenuated reperfusion injury. Reversal of APC by bracketing sevoflurane exposure with 5-HD suggests that APC is triggered by mitochondrial K channel opening or, alternatively, by attenuated mitochondrial respiration without direct involvement of mitochondrial K channel opening.
BACKGROUND:Ischemia causes an imbalance in mitochondrial metabolism and accumulation of nicotinamide adenine dinucleotide (NADH). We showed that anesthetic preconditioning (APC), like ischemic preconditioning, improved mitochondrial NADH energy balance during ischemia and improved function and reduced infarct size on reperfusion. Opening adenosine triphosphate-sensitive potassium (K(atp)) channels may be involved in triggering APC. The authors tested if effects of APC on NADH concentrations before, during, and after ischemia are reversible by 5-hydroxydecanoate (5-HD), a putative mitochondrial K channel blocker. METHODS:Nicotinamide adenine dinucleotide fluorescence was measured in 60 guinea pig Langendorff-prepared hearts assigned into five groups: (1) no treatment before ischemia; (2) APC by exposure to 1.3 mm sevoflurane for 15 min; (3) 200 microm 5-HD from 5 min before to 15 min after sevoflurane exposure; (4) 35 min 5-HD alone; and (5) no treatment and no ischemia. Sevoflurane was washed out for 30 min, and 5-HD for 15 min, before 30-min ischemia and 120-min reperfusion. RESULTS:Nicotinamide adenine dinucleotide was reversibly increased during sevoflurane exposure before ischemia, and the increase and rate of decline in NADH during ischemia were reduced after APC. 5-HD abolished these changes in NADH. On reperfusion, function was improved and infarct size reduced after APC compared with other groups. CONCLUSION: Anesthetic preconditioning was evidenced by improved mitochondrial bioenergetics as assessed from NADH concentrations during ischemia and by attenuated reperfusion injury. Reversal of APC by bracketing sevoflurane exposure with 5-HD suggests that APC is triggered by mitochondrial K channel opening or, alternatively, by attenuated mitochondrial respiration without direct involvement of mitochondrial K channel opening.
Authors: Matthias L Riess; Amadou K S Camara; André Heinen; Janis T Eells; Michele M Henry; David F Stowe Journal: J Cardiovasc Pharmacol Date: 2008-05 Impact factor: 3.105
Authors: Naoyuki Hirata; Yon Hee Shim; Danijel Pravdic; Nicole L Lohr; Philip F Pratt; Dorothee Weihrauch; Judy R Kersten; David C Warltier; Zeljko J Bosnjak; Martin Bienengraeber Journal: Anesthesiology Date: 2011-09 Impact factor: 7.892
Authors: Michele M Salzman; Qunli Cheng; Richard J Deklotz; Gurpreet K Dulai; Hunter F Douglas; Anna E Dikalova; Dorothee Weihrauch; Brian M Barnes; Matthias L Riess Journal: J Comp Physiol B Date: 2017-03-31 Impact factor: 2.200
Authors: Raha Nabbi; Ashish K Gadicherla; Judy R Kersten; David F Stowe; Jozef Lazar; Matthias L Riess Journal: Physiol Genomics Date: 2013-12-31 Impact factor: 3.107
Authors: Mette Funding la Cour; Shima Mehrvar; James S Heisner; Mohammad Masoudi Motlagh; Meetha Medhora; Mahsa Ranji; Amadou K S Camara Journal: J Biomed Opt Date: 2018-01 Impact factor: 3.170
Authors: Mahsa Ranji; Mohammad Masoudi Motlagh; Fahimeh Salehpour; Reyhaneh Sepehr; James S Heisner; Ranjan K Dash; Amadou K S Camara Journal: IEEE J Transl Eng Health Med Date: 2016-06-15 Impact factor: 3.316
Authors: David F Stowe; Amadou K S Camara; James S Heisner; Mohammed Aldakkak; David R Harder Journal: J Heart Lung Transplant Date: 2008-07-26 Impact factor: 10.247
Authors: Matthias L Riess; Samhita S Rhodes; David F Stowe; Mohammed Aldakkak; Amadou K S Camara Journal: J Pharmacol Toxicol Methods Date: 2009-09-03 Impact factor: 1.950